2021
DOI: 10.1096/fasebj.2021.35.s1.02995
|View full text |Cite
|
Sign up to set email alerts
|

Alcohol Worsens Cancer Cachexia and Anabolic Signaling in C26 Tumor Bearing Mice

Abstract: Cancer cachexia results in a loss of skeletal muscle mass, leading to increased morbidity and mortality. Similarly, chronic alcohol consumption leads to skeletal muscle loss and dysfunction. It is unknown, whether prior alcohol intake or its continued use after cancer establishment, exacerbates cancer cachexia. Anabolic pathways are central to the maintenance of muscle mass and are notoriously decreased by alcohol intake. Among these pathways, the mTORC1 pathway and subsequent rates of protein synthesis are of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
0
0
Order By: Relevance
“…In the context of cellular development, mTORC1 plays a crucial role in regulating the activity of unc-51-like autophagy-activating kinase 1 (ULK1) and ATG13. This regulation leads to a reduction in catabolic autophagy and an enhancement in protein synthesis mediated by 4E-BPs and p70S6K [49,50]. In another related pathway, MSTN makes its negative impact on muscle mass regulation by inducing ActRIIB, which phosphorylates SMAD2 and SMAD3, inhibiting Akt protein [51,52].…”
Section: Muscle Atrophymentioning
confidence: 99%
See 1 more Smart Citation
“…In the context of cellular development, mTORC1 plays a crucial role in regulating the activity of unc-51-like autophagy-activating kinase 1 (ULK1) and ATG13. This regulation leads to a reduction in catabolic autophagy and an enhancement in protein synthesis mediated by 4E-BPs and p70S6K [49,50]. In another related pathway, MSTN makes its negative impact on muscle mass regulation by inducing ActRIIB, which phosphorylates SMAD2 and SMAD3, inhibiting Akt protein [51,52].…”
Section: Muscle Atrophymentioning
confidence: 99%
“…The development of antibodies capable of inhibiting the actions of both myostatin and activin could, therefore, serve as a potential approach to mitigate muscle atrophy [143][144][145]. The crucial carcinogenic pathway PI3K/AKT/mTOR-also responsible for protein biosynthesis-is also effectively suppressed by myostatin and activin [49,50]. In contrast, Insulin-like growth factor 1 (IGF-1) is an important activator of the PI3K/Akt signaling pathway, which plays a crucial role in protein synthesis and the promotion of muscle growth [45,146].…”
Section: Potential Molecular Interventionsmentioning
confidence: 99%